Evenity 105 mg/1.17 mL prefilled syringe Images
Generic Name: romosozumab
This medication has been identified as Evenity 105 mg/1.17 mL prefilled syringe. It is supplied by Amgen Inc.
Evenity is used in the treatment of Osteoporosis and belongs to the drug class miscellaneous bone resorption inhibitors. Evenity 105 mg/1.17 mL prefilled syringe is not a controlled substance under the Controlled Substances Act (CSA).
Images of medication

Evenity
- Generic Name
- romosozumab
- Strength
- 105 mg/1.17 mL prefilled syringe
- Availability
- Prescription only
- Drug Class
- Miscellaneous bone resorption inhibitors
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Amgen Inc.
- National Drug Code (NDC)
- 55513-0880
See also:
Prolia
Prolia (denosumab) is an injection that is administered subcutaneously (under the skin) once every ...
Fosamax
Fosamax (alendronate) is used to treat or prevent postmenopausal osteoporosis and steroid-induced ...
Botox
Botox is used for cosmetic purposes and to treat overactive bladder symptoms, urinary incontinence ...
Premarin
Premarin is used to treat symptoms of menopause such as hot flashes, and vaginal dryness. Learn ...
Reclast
Reclast (zoledronic acid) is used to treat osteoporosis in women after menopause and also to treat ...
Zometa
Zometa is used to treat high blood levels of calcium caused by cancer and multiple myeloma. Learn ...
Boniva
Boniva (ibandronate) is used to treat or prevent osteoporosis in women after menopause. Includes ...
Atelvia
Atelvia (risedronate) is used to treat osteoporosis in women after menopause. Includes Atelvia side ...
Xgeva
Xgeva prevents bone fractures and other skeletal conditions in people with multiple myeloma, and is ...
More about Evenity (romosozumab)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (79)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: miscellaneous bone resorption inhibitors
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.